The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 4
  • 1
    Cerda Moya, Gustavo Andrés, Dr
    Scientist born in October 1980
    Individual (3 offsprings)
    Officer
    2015-05-20 ~ now
    OF - Director → CIF 0
    Mr Gustavo Cerda Moya
    Born in October 1980
    Individual (3 offsprings)
    Person with significant control
    2016-04-06 ~ now
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
  • 2
    Kinane, Denis Francis
    Company Director born in January 1957
    Individual (9 offsprings)
    Officer
    2022-06-20 ~ now
    OF - Director → CIF 0
  • 3
    Shaw, Benjamin Fraser Adam
    Director born in December 1988
    Individual (1 offspring)
    Officer
    2016-03-10 ~ now
    OF - Director → CIF 0
  • 4
    One, High Street, Egham, United Kingdom
    Active Corporate (2 parents, 1 offspring)
    Equity (Company account)
    1,865,729 GBP2024-02-29
    Officer
    2024-06-04 ~ now
    OF - Director → CIF 0
Ceased 5
  • 1
    Mason, William Thomas, Dr
    Company Director born in May 1951
    Individual (13 offsprings)
    Officer
    2015-06-04 ~ 2015-11-27
    OF - Director → CIF 0
  • 2
    Hussain, Sam
    Company Director born in October 1989
    Individual (2 offsprings)
    Officer
    2018-09-14 ~ 2023-02-06
    OF - Director → CIF 0
  • 3
    Collis, Mary Elin Marion
    Company Director born in December 1950
    Individual (2 offsprings)
    Officer
    2015-06-04 ~ 2015-11-27
    OF - Director → CIF 0
  • 4
    Burles, Barrington William
    Consultant born in March 1960
    Individual (4 offsprings)
    Officer
    2018-09-14 ~ 2023-02-06
    OF - Director → CIF 0
  • 5
    ISOSCELES FINANCE LIMITED - now
    ISOSCELES TECHNOLOGY LIMITED - 2001-06-13
    One, High Street, Egham, England
    Active Corporate (5 parents, 2 offsprings)
    Equity (Company account)
    631,180 GBP2022-08-31
    Officer
    2018-09-14 ~ 2024-06-04
    PE - Director → CIF 0
parent relation
Company in focus

CAMBRIDGE MOLECULAR DIAGNOSTICS LTD

Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Average Number of Employees
82023-02-01 ~ 2024-01-31
82022-04-01 ~ 2023-01-31
Intangible Assets
1,729,612 GBP2024-01-31
1,237,724 GBP2023-01-31
Property, Plant & Equipment
21,446 GBP2024-01-31
44,689 GBP2023-01-31
Fixed Assets
1,751,058 GBP2024-01-31
1,282,413 GBP2023-01-31
Total Inventories
2,789 GBP2024-01-31
1,539 GBP2023-01-31
Debtors
Current
174,965 GBP2024-01-31
180,818 GBP2023-01-31
Cash at bank and in hand
418,851 GBP2024-01-31
176,595 GBP2023-01-31
Current Assets
596,605 GBP2024-01-31
358,952 GBP2023-01-31
Creditors
Current, Amounts falling due within one year
-43,968 GBP2024-01-31
-785,727 GBP2023-01-31
Net Current Assets/Liabilities
552,637 GBP2024-01-31
-426,775 GBP2023-01-31
Total Assets Less Current Liabilities
2,303,695 GBP2024-01-31
855,638 GBP2023-01-31
Net Assets/Liabilities
2,303,695 GBP2024-01-31
855,638 GBP2023-01-31
Equity
Called up share capital
978 GBP2024-01-31
637 GBP2023-01-31
541 GBP2022-04-01
Share premium
3,257,774 GBP2024-01-31
1,507,804 GBP2023-01-31
908,919 GBP2022-04-01
Retained earnings (accumulated losses)
-955,057 GBP2024-01-31
-652,803 GBP2023-01-31
-411,995 GBP2022-04-01
Equity
2,303,695 GBP2024-01-31
855,638 GBP2023-01-31
497,465 GBP2022-04-01
Profit/Loss
Retained earnings (accumulated losses)
-302,254 GBP2023-02-01 ~ 2024-01-31
-240,808 GBP2022-04-01 ~ 2023-01-31
Profit/Loss
-302,254 GBP2023-02-01 ~ 2024-01-31
-240,808 GBP2022-04-01 ~ 2023-01-31
Comprehensive Income/Expense
Retained earnings (accumulated losses)
-302,254 GBP2023-02-01 ~ 2024-01-31
-240,808 GBP2022-04-01 ~ 2023-01-31
Comprehensive Income/Expense
-302,254 GBP2023-02-01 ~ 2024-01-31
-240,808 GBP2022-04-01 ~ 2023-01-31
Issue of Equity Instruments
Called up share capital
341 GBP2023-02-01 ~ 2024-01-31
96 GBP2022-04-01 ~ 2023-01-31
Issue of Equity Instruments
1,750,311 GBP2023-02-01 ~ 2024-01-31
598,981 GBP2022-04-01 ~ 2023-01-31
Equity - Income/Expense Recognised Directly
Called up share capital
341 GBP2023-02-01 ~ 2024-01-31
96 GBP2022-04-01 ~ 2023-01-31
Equity - Income/Expense Recognised Directly
1,750,311 GBP2023-02-01 ~ 2024-01-31
598,981 GBP2022-04-01 ~ 2023-01-31
Property, Plant & Equipment - Depreciation rate used
Plant and equipment
332023-02-01 ~ 2024-01-31
Office equipment
332023-02-01 ~ 2024-01-31
Computers
332023-02-01 ~ 2024-01-31
Wages/Salaries
21,123 GBP2023-02-01 ~ 2024-01-31
33,118 GBP2022-04-01 ~ 2023-01-31
Social Security Costs
2,594 GBP2023-02-01 ~ 2024-01-31
3,439 GBP2022-04-01 ~ 2023-01-31
Staff Costs/Employee Benefits Expense
24,116 GBP2023-02-01 ~ 2024-01-31
37,379 GBP2022-04-01 ~ 2023-01-31
Intangible Assets - Gross Cost
Patents/Trademarks/Licences/Concessions
188,462 GBP2024-01-31
154,278 GBP2023-01-31
Development expenditure
1,595,840 GBP2024-01-31
1,121,126 GBP2023-01-31
Intangible Assets - Gross Cost
1,784,302 GBP2024-01-31
1,275,404 GBP2023-01-31
Intangible Assets - Accumulated Amortisation & Impairment
Patents/Trademarks/Licences/Concessions
54,690 GBP2024-01-31
37,681 GBP2023-01-31
Intangible Assets - Accumulated Amortisation & Impairment
54,690 GBP2024-01-31
37,681 GBP2023-01-31
Intangible Assets - Increase From Amortisation Charge for Year
17,009 GBP2023-02-01 ~ 2024-01-31
Intangible Assets
Patents/Trademarks/Licences/Concessions
133,772 GBP2024-01-31
116,597 GBP2023-01-31
Development expenditure
1,595,840 GBP2024-01-31
1,121,126 GBP2023-01-31
Property, Plant & Equipment - Gross Cost
Plant and equipment
107,776 GBP2024-01-31
104,539 GBP2023-01-31
Office equipment
8,202 GBP2024-01-31
7,724 GBP2023-01-31
Computers
9,192 GBP2024-01-31
6,601 GBP2023-01-31
Property, Plant & Equipment - Gross Cost
125,170 GBP2024-01-31
118,864 GBP2023-01-31
Property, Plant & Equipment - Accumulated Depreciation (Not Including Impairment)
Plant and equipment
65,337 GBP2023-01-31
Office equipment
4,412 GBP2023-01-31
Computers
4,426 GBP2023-01-31
Property, Plant & Equipment - Accumulated Depreciation (Not Including Impairment)
74,175 GBP2023-01-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Plant and equipment, Owned/Freehold
25,919 GBP2023-02-01 ~ 2024-01-31
Office equipment, Owned/Freehold
1,795 GBP2023-02-01 ~ 2024-01-31
Computers, Owned/Freehold
1,835 GBP2023-02-01 ~ 2024-01-31
Owned/Freehold
29,549 GBP2023-02-01 ~ 2024-01-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment
91,256 GBP2024-01-31
Office equipment
6,207 GBP2024-01-31
Computers
6,261 GBP2024-01-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
103,724 GBP2024-01-31
Property, Plant & Equipment
Plant and equipment
16,520 GBP2024-01-31
39,202 GBP2023-01-31
Office equipment
1,995 GBP2024-01-31
3,312 GBP2023-01-31
Computers
2,931 GBP2024-01-31
2,175 GBP2023-01-31
Raw materials and consumables
2,789 GBP2024-01-31
1,539 GBP2023-01-31
Other Debtors
Current
143,393 GBP2024-01-31
157,444 GBP2023-01-31
Prepayments/Accrued Income
Current
31,572 GBP2024-01-31
23,374 GBP2023-01-31
Other Remaining Borrowings
Current
720,000 GBP2023-01-31
Trade Creditors/Trade Payables
Current
2,708 GBP2024-01-31
36,789 GBP2023-01-31
Taxation/Social Security Payable
Current
12,088 GBP2024-01-31
7,607 GBP2023-01-31
Other Creditors
Current
1,861 GBP2024-01-31
1,780 GBP2023-01-31
Accrued Liabilities/Deferred Income
Current
27,311 GBP2024-01-31
19,551 GBP2023-01-31
Creditors
Current
43,968 GBP2024-01-31
785,727 GBP2023-01-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
4,890 shares2024-01-31
3,186 shares2023-01-31
Par Value of Share
Class 1 ordinary share
0.202023-02-01 ~ 2024-01-31
Future Minimum Lease Payments Under Non-cancellable Operating Leases
Amounts falling due within one year
70,290 GBP2024-01-31
97,400 GBP2023-01-31
Between one and five year
71,363 GBP2024-01-31
198,070 GBP2023-01-31
Future Minimum Lease Payments Under Non-cancellable Operating Leases
141,653 GBP2024-01-31
295,470 GBP2023-01-31
  • CAMBRIDGE MOLECULAR DIAGNOSTICS LTD
    Info
    Registered number 09600771
    25 Science Park, Bio-innovation Centre, Milton Road, Cambridge CB4 0FW
    Private Limited Company incorporated on 2015-05-20 (10 years 1 month). The company status is Active.
    The last date of confirmation statement was made at 2025-02-17
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

qrcode

Privacy notice

© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.